| fMRI in the public eye E Racine, O Bar-Ilan, J Illes Nature Reviews Neuroscience 6 (2), 159-164, 2005 | 571 | 2005 |
| The concept of ‘vulnerability’in research ethics: an in-depth analysis of policies and guidelines D Bracken-Roche, E Bell, ME Macdonald, E Racine Health research policy and systems 15, 1-18, 2017 | 428 | 2017 |
| Contemporary neuroscience in the media E Racine, S Waldman, J Rosenberg, J Illes Social science & medicine 71 (4), 725-733, 2010 | 332 | 2010 |
| Imaging or imagining? A neuroethics challenge informed by genetics J Illes, E Racine The American Journal of Bioethics 5 (2), 5-18, 2005 | 327 | 2005 |
| Neurotalk: improving the communication of neuroscience research J Illes, MA Moser, JB McCormick, E Racine, S Blakeslee, A Caplan, ... Nature Reviews Neuroscience 11 (1), 61-69, 2010 | 268 | 2010 |
| Ethical aspects of brain computer interfaces: a scoping review S Burwell, M Sample, E Racine BMC medical ethics 18, 1-11, 2017 | 240 | 2017 |
| Pragmatic neuroethics: Improving treatment and understanding of the mind-brain E Racine Mit Press, 2010 | 208 | 2010 |
| Preparing the ethical future of deep brain stimulation E Bell, G Mathieu, E Racine Surgical neurology 72 (6), 577-586, 2009 | 188 | 2009 |
| Brain imaging: a decade of coverage in the print media E Racine, O Bar-Ilan, J Illes Science communication 28 (1), 122-143, 2006 | 172 | 2006 |
| Making autism research inclusive by attending to intersectionality: A review of the research ethics literature MA Cascio, JA Weiss, E Racine Review Journal of Autism and Developmental Disorders 8, 22-36, 2021 | 171 | 2021 |
| Ethical challenges arising in the COVID-19 pandemic: an overview from the Association of Bioethics Program Directors (ABPD) task force AL McGuire, MP Aulisio, FD Davis, C Erwin, TD Harter, R Jagsi, ... The American Journal of Bioethics 20 (7), 15-27, 2020 | 160 | 2020 |
| Cognitive enhancement, lifestyle choice or misuse of prescription drugs? Ethics blind spots in current debates E Racine, C Forlini Neuroethics 3, 1-4, 2010 | 157 | 2010 |
| Autonomy and coercion in academic “cognitive enhancement” using methylphenidate: Perspectives of key stakeholders C Forlini, E Racine Neuroethics 2, 163-177, 2009 | 156 | 2009 |
| The rising tide of tDCS in the media and academic literature V Dubljević, V Saigle, E Racine Neuron 82 (4), 731-736, 2014 | 147 | 2014 |
| Diagnosis and management of Alzheimer's disease: past, present and future ethical issues S Gauthier, A Leuzy, E Racine, P Rosa-Neto Progress in neurobiology 110, 102-113, 2013 | 143 | 2013 |
| Person-oriented research ethics: integrating relational and everyday ethics in research MA Cascio, E Racine Accountability in research 25 (3), 170-197, 2018 | 131 | 2018 |
| Public stigma toward people with drug addiction: A factorial survey S Sattler, A Escande, E Racine, AS Göritz Journal of studies on alcohol and drugs 78 (3), 415-425, 2017 | 130 | 2017 |
| Disorders of consciousness: responding to requests for novel diagnostic and therapeutic interventions RJ Jox, JL Bernat, S Laureys, E Racine The Lancet Neurology 11 (8), 732-738, 2012 | 130 | 2012 |
| “Currents of hope”: neurostimulation techniques in US and UK print media E Racine, S Waldman, N Palmour, D Risse, J Illes Cambridge Quarterly of Healthcare Ethics 16 (3), 312-316, 2007 | 124 | 2007 |
| Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement C Forlini, E Racine BMC Medical Ethics 10, 1-13, 2009 | 120 | 2009 |
Veljko Dubljevic, Ph.D., D.Phil.Professor of Philosophy and STS (Science, Technology & Society), NC State UniversityVerified email at ncsu.edu
